An advisory group said the U.S. fast-track approval process for medical devices is fatally flawed and should be replaced, but the Food and Drug Administration said the recommendation was a non-starter.

Popular Posts:

• Man dies feet from ER after hospital says to call 911
• Medical device maker Orthofix cuts restructures
• White House Axes Part of Health-Care Overhaul
• FDA advisers consider time limit for bone drugs
• FDA advisers consider time limit for bone drugs

Related Posts:

• U.S. advisers call for overhaul of FDA device approval process
• U.S. advisers call for overhaul of FDA device approval process
• U.S. advisers call for overhaul of FDA device approval process
• U.S. may speed approval of ‘breakthrough’ drugs
• Vaginal Mesh Complications Prompt New Bill To Amend FDA Device Approval Loophole